In 2009, ExxonMobil, the world's largest publicly traded oil and gas company, announced a research agreement with Synthetic Genomics Inc (SGI) for the joint development of algae to leverage SGI's capabilities in synthetic biology. The agreement was a momentous event in the algae industry, as it was the largest announced investment yet by a single company in algae development; ExxonMobil's promised investment was valued at $600 million and conditional upon the collaboration hitting specific but undisclosed milestones. While news reports suggest that these milestones were not reached in a timely manner, forcing ExxonMobil to readjust its goals, recent announcements indicate that breakthroughs have been reached over the past two years.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 (0) 20-3460840
For APAC (Singapore)